Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus
Document Type
Abstract
Publication Date
2018
Recommended Citation
Tsan, J., Duong, T., Girgis, N., Labib, M., Moustakas, A., & Loh, F. E. (2018). Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus. Value in Health, 21 (Suppl. 1), S75. https://doi.org/10.1016/j.jval.2018.04.503
Publisher's Statement
The original material can be found here: https://doi.org/10.1016/j.jval.2018.04.503
